Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 0 | 0 | 0 | 5,854 | 584 |
| Gross Profit | N/A | N/A | N/A | 5,854 | 584 |
| Operating Expenses | 11,879 | 6,764 | 8,184 | 18,546 | 6,228 |
| Operating Income | -11,879 | -6,764 | -8,184 | -12,692 | -5,644 |
| Interest Expense | 444 | 696 | 598 | 210 | 1,082 |
| Other Income | 6,037 | 1,760 | -7,821 | 172 | 1,508 |
| Pre-tax Income | -6,286 | -5,700 | -16,603 | -12,730 | -5,218 |
| Income Tax | -3,271 | N/A | N/A | -2,634 | -778 |
| Net Income Continuous | -3,015 | -5,700 | -16,603 | -10,096 | -4,441 |
| Net Income | $-3,015 | $-5,700 | $-16,603 | $-10,096 | $-4,441 |
| EPS Basic Total Ops | -0.60 | -7.20 | -12.40 | 4.00 | -4.00 |
| EPS Basic Continuous Ops | -0.66 | -2.38 | -11.11 | 3.47 | -3.86 |
| EPS Diluted Total Ops | -0.60 | -7.20 | -12.40 | 4.00 | -4.00 |
| EPS Diluted Continuous Ops | -0.66 | -2.38 | -11.11 | 3.47 | -3.86 |
| EBITDA(a) | $-11,757 | $-6,587 | $-8,009 | $-11,803 | $-4,811 |